Amendment_0002_-_15-100-SOL-00003.pdf

This notice provides details regarding a forthcoming request for proposal for medical countermeasures for pandemic influenza preparedness and response. The Department of Health and Human Services through the Biomedical Advanced Research and Development Authority Acquisition Management, Contracts and Grants directorate intends to issue a request for proposal seeking the supply of cGMP influenza vaccine master and working seed lots, research lots, investigational lots, commercial scale bulk lots, cGMP adjuvant in clinical or commercial scale bulk lots, formulation and filling services, storage and stability services, shipping, candidate vaccine viruses, potency reagents and standards manufacture and testing, analytical laboratory testing and assays, non-clinical studies, clinical studies, disposal of product, BARDA tracking tool development and testing of new standard data reporting formats, and additional reporting. Responses will be accepted from offerors able to produce vaccines against influenza and influenza strains with pandemic potential who have a U.S. influenza vaccine license or have completed phase 3 clinical trials and have a biologics license application in preparation. The base period of performance is three years with two optional one-year extensions. The request for proposal will be available on January 12, 2015 with proposals due February 20, 2015 and estimated contract awards in July 2015.